Quotes delayed at least 15 minutes. Market data provided by Factset.Dow Jones Indexes Terms & Conditions. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Mutual Fund and ETF data provided by Morningstar, Inc. Powered and implemented by FactSet Digital Solutions. Legal Statement.
|Mkt Cap||9.44 B|
|Next Earnings Date||n/a|
|52 Wk High||165.75|
|52 Wk Low||95.47|
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.